# Macro Trials

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/macro-trials

- Industry: Biotechnology
- Headquarters: Los Angeles, US
- Website: www.macrotrials.com
- Total disclosed funding: $6M
- Latest round: Seed (Jun 21, 2023)
- Investors on record: 5

## About

Based in California, US, and founded in 2021, Macro Trials, Inc., a.k.a. Macro Trials operates as a provider of a precision research clinical platform that engages in studies of accessible pharmaceutical drugs by partnering with pharmaceutical companies, CROs, providers, and health systems. In June 2023, Macro Trials raised USD 6 million in seed funding led by MBX Capital, with participation from Healthy Ventures, Inflect Health, Initiate Ventures, and Village Global.

The company provides a precision research clinical platform and proprietary real-world evidence as a service (RWEaaS) that enables physicians to participate in research work through workflow-native efficiency tools, clinical research personnel, and a network of logistic partners. The platform supports life science companies across research, development, and commercialization of therapeutics.

Macro Trials plans to use its proceeds from June 2023 funding for ongoing product development, scaling its study execution and data generation, and expanding its clinical trial infrastructure across geographies and therapeutic areas.

## Funding rounds

- Seed, Jun 21, 2023, $6M — Healthy Ventures, Village Global, MBX Capital, Inflect Health, Initiate Ventures

## Investors

- Healthy Ventures (https://capitalatlas.ai/funds/healthy-ventures) — Seed
- Village Global (https://capitalatlas.ai/funds/village-global) — Seed
- MBX Capital (https://capitalatlas.ai/funds/mbx-capital) — Seed
- Inflect Health (https://capitalatlas.ai/funds/inflect-health) — Seed
- Initiate Ventures (https://capitalatlas.ai/funds/initiate-ventures) — Seed